CUE - Cue Biopharma GAAP EPS of -$0.29 in-line revenue of $0.19M misses by $1.76M May, 09 2023 06:01 PM Cue Biopharma Inc. 2023-05-09 18:01:56 ET Cue Biopharma press release ( NASDAQ: CUE ): Q1 GAAP EPS of -$0.29 in-line. Revenue of $0.19M (-81.0% Y/Y) misses by $1.76M . For further details see: Cue Biopharma GAAP EPS of -$0.29 in-line, revenue of $0.19M misses by $1.76M